SC
AMGN icon

Scotia Capital’s Amgen AMGN Stock Holding History

Scotia Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,000
Closed -$3.25M – 680
2015
Q4 		$3.25M Sell
20,000
-31,500
-61% -$4.95M 0.07% 193
2015
Q3 		$7.12M Buy
51,500
+31,500
+158% +$4.97M 0.16% 100
2015
Q2 		$3.07M Buy
+20,000
New +$3.2M 0.06% 218

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Scotia Capital's AMGN Position: Q1 2026 in Review

Scotia Capital increased its Amgen (AMGN) stake by 0.86% in Q1 2026, buying an estimated $103K and bringing the position to 33,751 shares worth $11.9M. The position accounts for 0.05% of the portfolio, ranked #194.

Scotia Capital first reported a position in AMGN in Q3 2013 and has held it in 50 quarters since. The position peaked at $16.5M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Scotia Capital held 33,751 shares of Amgen worth $11.9M as of Q1 2026.
  • Scotia Capital bought 288 Amgen shares in Q1 2026, an estimated $103K.
  • Amgen made up 0.05% of Scotia Capital's portfolio in Q1 2026, its #194 holding.
  • Scotia Capital first reported a position in Amgen in Q3 2013 and has held it in 50 quarters since.
  • Scotia Capital's Amgen position peaked at $16.5M in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.